ArticleScience translational medicine2017

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.

Parker L Sulkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.